- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Cano Health, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 11.04. | Cano Health, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 01.04. | Cano Health, Inc. - 10-K, Annual Report | 2 | SEC Filings | ||
| 25.03. | Cano Health, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 21.03. | Cano Health sells shares of MSP Recovery for $89,534 | 6 | Investing.com | ||
| 19.03. | Cano Health executives sell over $114k in MSP Recovery shares | 4 | Investing.com | ||
| 18.03. | Cano Health, Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | 1 | SEC Filings | ||
| 12.03. | Cano Health, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 08.02. | Why Experts Saw Cano Health's Bankruptcy Coming From A Mile Away | 7 | MedCity News | ||
| 06.02. | NSE - Cano Health, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | 1 | SEC Filings | ||
| 05.02. | Cano Health to be delisted from NYSE amid bankruptcy filing | 3 | Investing.com | ||
| 05.02. | Cano Health says NYSE will begin delisting procedure for co's stock | 2 | Seeking Alpha | ||
| 05.02. | NYSE Suspends Trading in Cano Health, Inc. (CANO) and Commences Delisting Proceedings | 320 | PR Newswire | MIAMI, Feb. 5, 2024 /PRNewswire/ -- Cano Health, Inc. (NYSE: CANO) ("Cano Health" or the "Company") announced today that on February 5, 2024, the New York Stock Exchange (the "NYSE") notified the... ► Artikel lesen | |
| 05.02. | In a 'spectacular collapse,' Cano Health files for bankruptcy | 2 | FierceHealthcare | ||
| 05.02. | Adverum Biotechnologies, Cano Health among healthcare movers | 3 | Seeking Alpha | ||
| 05.02. | US-Vorbörse: Nvidia, Cano Health, Catalent und Estee Lauder mit viel Bewegung | 14 | Investing.com Deutsch | ||
| 05.02. | Why Is Cano Health (CANO) Stock Down 51% Today? | 1 | InvestorPlace | ||
| 05.02. | Cano Health, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 05.02. | Why Is Primary Care Provider Cano Health Stock Trading Lower Today? | 1 | Benzinga.com | ||
| 05.02. | Cano Health initiates Chapter 11 and secures new funding | 2 | Investing.com |
Seite:
1 2 3 Weiter >>
48 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDTRONIC | 75,77 | -0,25 % | Medtronic: Americans Favor Quality Over Quantity in Pursuit of Longevity | According to a new survey from Medtronic and Morning Consult, nearly two-thirds of U.S. adults say they'd opt for a shorter, healthier life than a longer one with health issuesDUBLIN, IRELAND / ACCESSWIRE... ► Artikel lesen | |
| INTUITIVE SURGICAL | 353,95 | +0,48 % | Opening Bell: Wall Street mit erneutem Erholungsversuch; Netflix vor Zahlen, Intuitive Surgical, ... | Die US-Aktienmärkte dürften am Donnerstag mit freundlich eröffnen. Rund eine Dreiviertelstunde vor dem Sitzungsstart taxierte der Broker IG den Dow Jones Industrial rund 0,2 Prozent höher auf 37 820... ► Artikel lesen | |
| STRATEC | 41,600 | +0,48 % | Minimale Kursveränderung bei Stratec-Aktie (40,00 €) | Der Kurs der dem Anteilsschein von Stratec kommt kaum von der Stelle. Zuletzt zahlten Investoren für das Wertpapier 40,00 Euro. Einen minimalen Wertverlust von 0,12 Prozent zeigt die Kurstafel für die... ► Artikel lesen | |
| ROKU | 57,80 | +0,19 % | Hemisphere Media Group Launches WAPA+ on the Roku Channel | ||
| EUROFINS SCIENTIFIC | 57,80 | -4,46 % | Eurofins Scientific SE: Eurofins Achieves Organic Growth of 6.8% in Q1 2024, Ahead of Its Objectives | Regulatory News:
The Eurofins (Paris:ERF) network of companies continues to deliver resilient growth:
Reported revenues in Q1 2024 totalled €1,653m, an increase of 5.0% vs Q1 2023, driven... ► Artikel lesen | |
| M1 KLINIKEN | 13,450 | +0,37 % | M1 Kliniken weiter auf Wachstumskurs | Die M1 Kliniken AG veröffentlicht vorläufige IFRS-Zahlen zum Geschäftsjahr 2023. Im abgelaufenen Geschäftsjahr konnte die M1-Gruppe ihre Marktposition im Bereich der Schönheitsmedizin weiter ausbauen... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 1,366 | -1,58 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Presents Data from 40mg Cohort of Phase 2 EVANGELINE Clinical Trial Showing 100% Disease Control Rate After 24-Weeks of Treatment with (Z)-Endoxifen | SEATTLE, April 09, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company") today announced promising safety and efficacy data from the Company's Phase 2 EVANGELINE... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023 | -- Third Consecutive Year of Phexxi Net Sales Growth --
-- Total Operating Expense Reduced 64% from 2022 Levels --
-- Sales and marketing expense as a percentage of net sales was 54% for the fourth... ► Artikel lesen | |
| RYMAN HEALTHCARE | 2,302 | +0,88 % | RYMAN HEALTHCARE LIMITED: Group CEO Update | ||
| ZIMMER BIOMET | 112,80 | -0,62 % | What's in the Cards for Zimmer Biomet (ZBH) in Q1 Earnings? | ||
| QUIDELORTHO | 36,600 | -3,17 % | QuidelOrtho Reports Fourth Quarter and Full-Year 2023 Financial Results | SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care... ► Artikel lesen | |
| VERU | 1,220 | +2,43 % | LI, VERU and MRIN among pre-market losers | ||
| TEMPEST THERAPEUTICS | 3,150 | -1,32 % | Tempest Therapeutics: Tempest Announces Publication of Positive Data from Phase 1 Trial of TPST-1120 in Patients with Advanced Solid Tumors in Journal of Cancer Research Communications | TPST-1120, a first-in-class, oral, selective PPAR? antagonist, demonstrates clinical activity in PD-1 inhibitor refractory and immune compromised cancersBased on subsequent positive randomized data... ► Artikel lesen | |
| CENTENE | 71,04 | +0,25 % | Centene-Aktie legt um 0,84 Prozent zu (71,0929 €) | Im Plus liegt aktuell das Wertpapier von Centene . Das Papier kostete zuletzt 75,78 US-Dollar. Heute hat sich an der US-amerikanischen Börse die Centene-Aktie zwischenzeitlich um 0,84 Prozent verteuert.... ► Artikel lesen | |
| PERSPECTIVE THERAPEUTICS | 1,550 | -2,52 % | Perspective Therapeutics, Inc.: Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Year 2023 Financial Results | SEATTLE, March 28, 2024 (GLOBE NEWSWIRE) -- Perspective, Therapeutics, Inc. (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout... ► Artikel lesen |
CANO HEALTH INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 2,310 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
